Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global anti-obesity drugs market reached a value of US$ 1.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.63 Billion by 2027, exhibiting a CAGR of 12.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They help reduce cravings and control compulsive eating, especially for sweets and fatty, salty, and high-calorie food products. They can also provide independent health benefits, such as controlling blood pressure, harmful lipid levels, waist circumference, sugar levels and nonalcoholic fatty liver disease (NAFLD) and minimize the risk of major cardiovascular diseases (CVDs) and progression of diabetic kidney disease.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Anti-Obesity Drugs Market Trends:

Recent advances in anti-obesity drugs have enabled the potential of attaining clinically significant weight loss among individuals. This, in confluence with the widespread prevalence of obesity on account of sedentary lifestyles, represents one of the key factors creating a positive outlook for the market. In addition, obesity increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases (CVD), and cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. It can also result in numerous psychological, neurological, pulmonary, gastrointestinal, renal, musculoskeletal, and endocrine diseases. Besides this, sleep deprivation, circadian desynchronization, chronic stress, and the rising use of anti-epileptic and psychotropic drugs may further induce weight gain. This, coupled with the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings, is fueling the growth of the market. Apart from this, weight loss aids in improving the quality of life, mobility, daily function, and psychological well-being of individuals. This, along with the increasing health consciousness, thriving pharmaceutical industry, and the rising focus on the management of diseases closely integrated with excess body weight, is anticipated to stimulate the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-obesity drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, drug type and distribution channel.

Breakup by Drug Class:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Peripherally Acting Drugs
  • Centrally Acting Drugs
     

Breakup by Drug Type:

  • Prescription Drugs
  • OTC Drugs
     

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, Gelesis, GlaxoSmithKline plc, Merck & Co. Inc., Norgine B.V., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals Inc., SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Vivus LLC.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Drug Class, Drug Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, Gelesis, GlaxoSmithKline plc, Merck & Co. Inc., Norgine B.V., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals Inc., SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Vivus LLC.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global anti-obesity drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-obesity drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-obesity drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Anti-Obesity Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Peripherally Acting Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Centrally Acting Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Drug Type
    7.1    Prescription Drugs
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    OTC Drugs
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Boehringer Ingelheim International GmbH
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Currax Pharmaceuticals LLC
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Gelesis
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    GlaxoSmithKline plc
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Merck & Co. Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Norgine B.V.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Novo Nordisk A/S 
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Rhythm Pharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    SHIONOGI & Co. Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Vivus LLC
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Anti-Obesity Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Anti-Obesity Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Anti-Obesity Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Anti-Obesity Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Anti-Obesity Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Anti-Obesity Drugs (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Anti-Obesity Drugs (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: North America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: North America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: United States: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: United States: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Canada: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Canada: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Asia-Pacific: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Asia-Pacific: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: China: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: China: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Japan: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Japan: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: India: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: India: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: South Korea: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: South Korea: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Australia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Australia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Indonesia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Indonesia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Europe: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Europe: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Germany: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Germany: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: France: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: France: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: United Kingdom: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: United Kingdom: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Italy: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Italy: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Spain: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Spain: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Russia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Russia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Latin America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Latin America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Brazil: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Brazil: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Mexico: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Mexico: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: Anti-Obesity Drugs Market: Breakup by Country (in %), 2021
Figure 70: Middle East and Africa: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Global: Anti-Obesity Drugs Industry: SWOT Analysis
Figure 72: Global: Anti-Obesity Drugs Industry: Value Chain Analysis
Figure 73: Global: Anti-Obesity Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-Obesity Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 4: Global: Anti-Obesity Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Anti-Obesity Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Anti-Obesity Drugs Market: Competitive Structure
Table 7: Global: Anti-Obesity Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links